𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Category IV indications for therapeutic apheresis—ASFA fourth special issue

✍ Scribed by Beth H. Shaz; Michael L. Linenberger; Nicholas Bandarenko; Jeffrey L. Winters; Haewon C. Kim; Marisa B. Marques; Ravindra Sarode; Joseph Schwartz; Robert Weinstein; Ashka Wirk; Zbigniew M. Szczepiorkowski


Publisher
John Wiley and Sons
Year
2007
Tongue
English
Weight
98 KB
Volume
22
Category
Article
ISSN
0733-2459

No coin nor oath required. For personal study only.

✦ Synopsis


Abstract

The American Society for Apheresis (ASFA) Committee on Clinical Applications systematically and critically reviews published information on the use of therapeutic apheresis in clinical practice. On the basis of this review, selected diseases are assigned one of five categories (category I, II, III, IV, and P). The diseases, which were classified as category IV indications, and the rationale for such assignment are reviewed in this article. The diseases assigned to category I, II, III, and newly created category P are discussed in a separate article in this issue. J. Clin. Apheresis, 2007 © 2007 Wiley‐Liss, Inc.


📜 SIMILAR VOLUMES


The new approach to assignment of ASFA c
✍ Zbigniew M. Szczepiorkowski; Beth H. Shaz; Nicholas Bandarenko; Jeffrey L. Winte 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 351 KB 👁 1 views

## Abstract The American Society for Apheresis (ASFA) Apheresis Applications Committee is responsible for a review and categorization of indications for therapeutic apheresis. The results of the review process were previously published in 1986, 1993, and 2000 as the ASFA Special Issues. The ASFA ca